Apomorphine delays simple reaction time in Parkinsonian patients

Parkinsonism and Related Disorders

Volumn 8, Issue 5, 2002, Pages 357-360

  Müller, Thomas ^a   Benz, Sabine ^a   Przuntek, Horst ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Apomorphine; Parkinson's disease; Simple reaction time

Indexed keywords

APOMORPHINE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG RECEPTOR BINDING; FATIGUE; FEMALE; HUMAN; LOCOMOTION; MALE; NEUROTRANSMISSION; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REACTION TIME; TREATMENT OUTCOME; YAWNING;

ADULT; AGED; ANTIPARKINSON AGENTS; APOMORPHINE; COGNITION; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; MOVEMENT; PARKINSON DISEASE; REACTION TIME;

EID: 0036092725     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(01)00046-3     Document Type: Article

References (43)

1. Simple and choice reaction time and the use of advance information for motor preparation in Parkinson's disease
2. Usefulness of movement time in the assessment of Parkinson's disease
3. The neurobiological basis of movement initiation
4. A meta-analysis on cognitive slowing in Parkinson's disease: Are simple and choice reaction times differentially impaired?
5. The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease
6. A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease
7. Sleep attacks and Parkinson's disease treatment [letter] [see comments]
8. Sleep episodes in Parkinson's disease: A wake-up call [editorial]
9. Sleep attacks in Parkinson's disease [letter; Comment]
10. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases [see comments]
11. Challenge tests to predict the dopaminergic response in untreated Parkinson's disease
12. Domperidone and Parkinson's disease
13. Core assessment program for intracerebral transplantations (CAPIT)
14. Effect of practice on performance of a skilled motor task in patients with Parkinson's disease
15. Preparation of manual movements in hemiparkinsonism
16. Reaction time in Parkinson's disease
17. Cognitive components of reaction time in Parkinson's disease
18. Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: An electrophysiological investigation
19. Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease
20. Movement amplitude choice reaction time performance in Parkinson's disease may be independent of dopaminergic status
21. Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment
22. Usefulness of movement time in the assessment of Parkinson's disease
23. Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease
24. Motor and cognitive performances of Parkinsonian patients in the on and off phases of the disease
25. Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's disease
26. Reaction time and movement velocity abnormalities in Parkinson's disease under different task conditions
27. Motor response to repeated dopaminergic stimulation in Parkinson's disease
28. Cognition and the basal ganglia.Separating mental and motor components of performance in Parkinson's disease
29. Movement characteristics in Parkinson's disease: Determination of dopaminergic responsiveness and threshold
30. Apomorphine doses impair the reaction time of fast reacting but not slow reacting rats
31. Fluctuations in plasma dopamine level impair memory in Parkinson's disease
32. Dose-dependent memory impairment in Parkinson's disease
33. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: The 15-objects test
34. Does cognitive impairment in Parkinson's disease result from non- dopaminergic lesions?
35. Pharmacologic strategies for augmenting cognitive performance in schizophrenia
36. The pharmacology of memory
37. Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: An electrophysiological study
38. Apomorphine induced cognitive changes in Parkinson's disease
39. Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease
40. Dopamine auto- and postsynaptic receptors: Electrophysiological evidence for differential sensitivity to dopamine agonists
41. Blockade of apomorphine-induced yawning in rats by the dopamine autoreceptor antagonist (+)-AJ 76
42. Electroencephalographic correlates of the sedative effects of dopamine agonists presumably acting on autoreceptors
43. Dopamine autoreceptor function is lost in advanced Parkinson's disease